Media

In a new white paper issued today, BIO updates the results of a study of the greenhouse gas emissions resulting from EPA's proposal to reduce biofuel use...
BIO is pleased to announce the creation of the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology to be presented to an outstanding...

Press Releases

Feb 16 2001
Washington, D.C. – A record 32 biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug Administration...
Feb 15 2001
WASHINGTON, D.C. (February 15, 2001) -- Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement today on...
Feb 14 2001
WASHINGTON, D.C. (February 14, 2001) – U.S. Sen. Tim Hutchinson (R-Arkansas) and Newt Gingrich, former Speaker of the U.S. House of Representatives, will be...
Feb 12 2001
WASHINGTON, D.C. (February 12, 2001) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on...
Feb 1 2001
WASHINGTON, D.C. (February 1, 2001) – Following recent announcements by certain groups of plans to clone human beings, the Biotechnology Industry Organization...
Feb 1 2001
The Honorable George W. BushPresident of the United StatesThe White House1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr. President: Recently certain...
Jan 30 2001
WASHINGTON, DC (January 30, 2001) –Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on President...
Jan 25 2001
WASHINGTON, D.C. (January 25, 2001) – The BiotechnologyIndustry Organization’s (BIO) CEO & Investor Conference next month in New York will showcase the...
Jan 17 2001
(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding a notice of an FDA proposed rule...


Biotechnology News

October 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Therapeutics will report third quarter 2014 financial results on Thursday, November 6, 2014. BIND’s management team will host a...

October 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics appointed industry veteran Wendy L. Dixon, PhD, former Chief Marketing Officer and President of Global Marketing...

October 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with...

October 23, 2014

CONCORD, Calif.--(BUSINESS WIRE)--The American Red Cross will participate in Cerus’ clinical protocol to make INTERCEPT Platelets available under an Expanded Access IDE to...

October 23, 2014

BURLINGAME, Calif.--(BUSINESS WIRE)--Igenica Biotherapeutics, Inc., a company focused on the discovery and development of innovative antibody-drug conjugates (ADCs) for...